Gacita, Sittie E.
HRN: 15-41-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2024
CEFUROXIME 1.5GM (VIAL)
06/14/2024
06/21/2024
IVT
1.5 Gms
Q 8 Hrs
Inevitable Abortion
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes